世界の1型糖尿病治療薬市場インサイト及び予測(~2026年)

【英語タイトル】Global Type 1 Diabetes Drugs Market Insights and Forecast to 2026

QYResearchが出版した調査資料(QYR20NV12796)・商品コード:QYR20NV12796
・発行会社(調査会社):QYResearch
・発行日:2020年11月(※2024年版があります。お問い合わせください)
・ページ数:111
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:医療、製薬
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査レポートは1型糖尿病治療薬の世界市場について調査・分析した資料です。種類別(インスリン、その他)の市場規模、用途別(ドラッグストア、病院、その他)の市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)の市場規模データ、主な企業情報と企業別市場シェア等が記載されています。
・調査範囲
・エグゼクティブサマリー
・企業別1型糖尿病治療薬の競争状況、市場シェア
・世界の1型糖尿病治療薬市場:種類別市場規模 2015年-2020年(インスリン、その他)
・世界の1型糖尿病治療薬市場:種類別市場規模予測 2021年-2026年(インスリン、その他)
・世界の1型糖尿病治療薬市場:用途別市場規模 2015年-2020年(ドラッグストア、病院、その他)
・世界の1型糖尿病治療薬市場:用途別市場規模予測 2021年-2026年(ドラッグストア、病院、その他)
・北米の1型糖尿病治療薬市場分析:米国、カナダ
・ヨーロッパの1型糖尿病治療薬市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアの1型糖尿病治療薬市場分析:日本、中国、韓国、インド、オーストラリア、台湾等
・中南米の1型糖尿病治療薬市場分析:メキシコ、ブラジル、アルゼンチン等
・中東・アフリカの1型糖尿病治療薬市場分析:トルコ、サウジアラビア、UAE等
・企業情報(企業概要、製品概要、販売量、企業動向)
- 掲載企業(変更可能性あり):Novo Nordisk、Sanofi、Eli Lily、Adocia、Astellas Pharma、AstraZeneca、BHV Pharma、Biodel、Boehringer Ingelheim、Diamyd Therapeutics AB
・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論
【レポートの概要】

Market Analysis and Insights: Global Type 1 Diabetes Drugs Market
The global Type 1 Diabetes Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Type 1 Diabetes Drugs Scope and Market Size
Type 1 Diabetes Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Type 1 Diabetes Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Type 1 Diabetes Drugs market is segmented into
Insulins
Others

Segment by Application, the Type 1 Diabetes Drugs market is segmented into
Drugstore
Hospital
Others

Regional and Country-level Analysis
The Type 1 Diabetes Drugs market is analysed and market size information is provided by regions (countries).
The key regions covered in the Type 1 Diabetes Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Type 1 Diabetes Drugs Market Share Analysis
Type 1 Diabetes Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Type 1 Diabetes Drugs business, the date to enter into the Type 1 Diabetes Drugs market, Type 1 Diabetes Drugs product introduction, recent developments, etc.

The major vendors covered:
Novo Nordisk
Sanofi
Eli Lily
Adocia
Astellas Pharma
AstraZeneca
BHV Pharma
Biodel
Boehringer Ingelheim
Diamyd Therapeutics AB

【レポートの目次】

1 Study Coverage
1.1 Type 1 Diabetes Drugs Product Introduction
1.2 Market Segments
1.3 Key Type 1 Diabetes Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Type 1 Diabetes Drugs Market Size Growth Rate by Type
1.4.2 Insulins
1.4.3 Others
1.5 Market by Application
1.5.1 Global Type 1 Diabetes Drugs Market Size Growth Rate by Application
1.5.2 Drugstore
1.5.3 Hospital
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Type 1 Diabetes Drugs Market Size, Estimates and Forecasts
2.1.1 Global Type 1 Diabetes Drugs Revenue 2015-2026
2.1.2 Global Type 1 Diabetes Drugs Sales 2015-2026
2.2 Global Type 1 Diabetes Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Type 1 Diabetes Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Type 1 Diabetes Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Type 1 Diabetes Drugs Competitor Landscape by Players
3.1 Type 1 Diabetes Drugs Sales by Manufacturers
3.1.1 Type 1 Diabetes Drugs Sales by Manufacturers (2015-2020)
3.1.2 Type 1 Diabetes Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 Type 1 Diabetes Drugs Revenue by Manufacturers
3.2.1 Type 1 Diabetes Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Type 1 Diabetes Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Type 1 Diabetes Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Type 1 Diabetes Drugs Revenue in 2019
3.2.5 Global Type 1 Diabetes Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Type 1 Diabetes Drugs Price by Manufacturers
3.4 Type 1 Diabetes Drugs Manufacturing Base Distribution, Product Types
3.4.1 Type 1 Diabetes Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Type 1 Diabetes Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Type 1 Diabetes Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Type 1 Diabetes Drugs Market Size by Type (2015-2020)
4.1.1 Global Type 1 Diabetes Drugs Sales by Type (2015-2020)
4.1.2 Global Type 1 Diabetes Drugs Revenue by Type (2015-2020)
4.1.3 Type 1 Diabetes Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Type 1 Diabetes Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global Type 1 Diabetes Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Type 1 Diabetes Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Type 1 Diabetes Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Type 1 Diabetes Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
5.1 Global Type 1 Diabetes Drugs Market Size by Application (2015-2020)
5.1.1 Global Type 1 Diabetes Drugs Sales by Application (2015-2020)
5.1.2 Global Type 1 Diabetes Drugs Revenue by Application (2015-2020)
5.1.3 Type 1 Diabetes Drugs Price by Application (2015-2020)
5.2 Type 1 Diabetes Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global Type 1 Diabetes Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Type 1 Diabetes Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Type 1 Diabetes Drugs Price Forecast by Application (2021-2026)

6 North America
6.1 North America Type 1 Diabetes Drugs by Country
6.1.1 North America Type 1 Diabetes Drugs Sales by Country
6.1.2 North America Type 1 Diabetes Drugs Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Type 1 Diabetes Drugs Market Facts & Figures by Type
6.3 North America Type 1 Diabetes Drugs Market Facts & Figures by Application

7 Europe
7.1 Europe Type 1 Diabetes Drugs by Country
7.1.1 Europe Type 1 Diabetes Drugs Sales by Country
7.1.2 Europe Type 1 Diabetes Drugs Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Type 1 Diabetes Drugs Market Facts & Figures by Type
7.3 Europe Type 1 Diabetes Drugs Market Facts & Figures by Application

8 Asia Pacific
8.1 Asia Pacific Type 1 Diabetes Drugs by Region
8.1.1 Asia Pacific Type 1 Diabetes Drugs Sales by Region
8.1.2 Asia Pacific Type 1 Diabetes Drugs Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Type 1 Diabetes Drugs Market Facts & Figures by Type
8.3 Asia Pacific Type 1 Diabetes Drugs Market Facts & Figures by Application

9 Latin America
9.1 Latin America Type 1 Diabetes Drugs by Country
9.1.1 Latin America Type 1 Diabetes Drugs Sales by Country
9.1.2 Latin America Type 1 Diabetes Drugs Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Type 1 Diabetes Drugs Market Facts & Figures by Type
9.3 Central & South America Type 1 Diabetes Drugs Market Facts & Figures by Application

10 Middle East and Africa
10.1 Middle East and Africa Type 1 Diabetes Drugs by Country
10.1.1 Middle East and Africa Type 1 Diabetes Drugs Sales by Country
10.1.2 Middle East and Africa Type 1 Diabetes Drugs Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Type 1 Diabetes Drugs Market Facts & Figures by Type
10.3 Middle East and Africa Type 1 Diabetes Drugs Market Facts & Figures by Application

11 Company Profiles
11.1 Novo Nordisk
11.1.1 Novo Nordisk Corporation Information
11.1.2 Novo Nordisk Description and Business Overview
11.1.3 Novo Nordisk Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Novo Nordisk Type 1 Diabetes Drugs Products Offered
11.1.5 Novo Nordisk Related Developments
11.2 Sanofi
11.2.1 Sanofi Corporation Information
11.2.2 Sanofi Description and Business Overview
11.2.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Sanofi Type 1 Diabetes Drugs Products Offered
11.2.5 Sanofi Related Developments
11.3 Eli Lily
11.3.1 Eli Lily Corporation Information
11.3.2 Eli Lily Description and Business Overview
11.3.3 Eli Lily Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Eli Lily Type 1 Diabetes Drugs Products Offered
11.3.5 Eli Lily Related Developments
11.4 Adocia
11.4.1 Adocia Corporation Information
11.4.2 Adocia Description and Business Overview
11.4.3 Adocia Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Adocia Type 1 Diabetes Drugs Products Offered
11.4.5 Adocia Related Developments
11.5 Astellas Pharma
11.5.1 Astellas Pharma Corporation Information
11.5.2 Astellas Pharma Description and Business Overview
11.5.3 Astellas Pharma Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Astellas Pharma Type 1 Diabetes Drugs Products Offered
11.5.5 Astellas Pharma Related Developments
11.6 AstraZeneca
11.6.1 AstraZeneca Corporation Information
11.6.2 AstraZeneca Description and Business Overview
11.6.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
11.6.4 AstraZeneca Type 1 Diabetes Drugs Products Offered
11.6.5 AstraZeneca Related Developments
11.7 BHV Pharma
11.7.1 BHV Pharma Corporation Information
11.7.2 BHV Pharma Description and Business Overview
11.7.3 BHV Pharma Sales, Revenue and Gross Margin (2015-2020)
11.7.4 BHV Pharma Type 1 Diabetes Drugs Products Offered
11.7.5 BHV Pharma Related Developments
11.8 Biodel
11.8.1 Biodel Corporation Information
11.8.2 Biodel Description and Business Overview
11.8.3 Biodel Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Biodel Type 1 Diabetes Drugs Products Offered
11.8.5 Biodel Related Developments
11.9 Boehringer Ingelheim
11.9.1 Boehringer Ingelheim Corporation Information
11.9.2 Boehringer Ingelheim Description and Business Overview
11.9.3 Boehringer Ingelheim Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Boehringer Ingelheim Type 1 Diabetes Drugs Products Offered
11.9.5 Boehringer Ingelheim Related Developments
11.10 Diamyd Therapeutics AB
11.10.1 Diamyd Therapeutics AB Corporation Information
11.10.2 Diamyd Therapeutics AB Description and Business Overview
11.10.3 Diamyd Therapeutics AB Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Diamyd Therapeutics AB Type 1 Diabetes Drugs Products Offered
11.10.5 Diamyd Therapeutics AB Related Developments
11.1 Novo Nordisk
11.1.1 Novo Nordisk Corporation Information
11.1.2 Novo Nordisk Description and Business Overview
11.1.3 Novo Nordisk Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Novo Nordisk Type 1 Diabetes Drugs Products Offered
11.1.5 Novo Nordisk Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Type 1 Diabetes Drugs Market Estimates and Projections by Region
12.1.1 Global Type 1 Diabetes Drugs Sales Forecast by Regions 2021-2026
12.1.2 Global Type 1 Diabetes Drugs Revenue Forecast by Regions 2021-2026
12.2 North America Type 1 Diabetes Drugs Market Size Forecast (2021-2026)
12.2.1 North America: Type 1 Diabetes Drugs Sales Forecast (2021-2026)
12.2.2 North America: Type 1 Diabetes Drugs Revenue Forecast (2021-2026)
12.2.3 North America: Type 1 Diabetes Drugs Market Size Forecast by Country (2021-2026)
12.3 Europe Type 1 Diabetes Drugs Market Size Forecast (2021-2026)
12.3.1 Europe: Type 1 Diabetes Drugs Sales Forecast (2021-2026)
12.3.2 Europe: Type 1 Diabetes Drugs Revenue Forecast (2021-2026)
12.3.3 Europe: Type 1 Diabetes Drugs Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Type 1 Diabetes Drugs Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Type 1 Diabetes Drugs Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Type 1 Diabetes Drugs Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Type 1 Diabetes Drugs Market Size Forecast by Region (2021-2026)
12.5 Latin America Type 1 Diabetes Drugs Market Size Forecast (2021-2026)
12.5.1 Latin America: Type 1 Diabetes Drugs Sales Forecast (2021-2026)
12.5.2 Latin America: Type 1 Diabetes Drugs Revenue Forecast (2021-2026)
12.5.3 Latin America: Type 1 Diabetes Drugs Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Type 1 Diabetes Drugs Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Type 1 Diabetes Drugs Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Type 1 Diabetes Drugs Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Type 1 Diabetes Drugs Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Type 1 Diabetes Drugs Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Type 1 Diabetes Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables
Table 1. Type 1 Diabetes Drugs Market Segments
Table 2. Ranking of Global Top Type 1 Diabetes Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Type 1 Diabetes Drugs Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Insulins
Table 5. Major Manufacturers of Others
Table 6. Global Type 1 Diabetes Drugs Market Size Growth Rate by Application 2020-2026 (K Units)
Table 7. Global Type 1 Diabetes Drugs Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 8. Global Type 1 Diabetes Drugs Sales by Regions 2015-2020 (K Units)
Table 9. Global Type 1 Diabetes Drugs Sales Market Share by Regions (2015-2020)
Table 10. Global Type 1 Diabetes Drugs Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global Type 1 Diabetes Drugs Sales by Manufacturers (2015-2020) (K Units)
Table 12. Global Type 1 Diabetes Drugs Sales Share by Manufacturers (2015-2020)
Table 13. Global Type 1 Diabetes Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 14. Global Type 1 Diabetes Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Type 1 Diabetes Drugs as of 2019)
Table 15. Type 1 Diabetes Drugs Revenue by Manufacturers (2015-2020) (US$ Million)
Table 16. Type 1 Diabetes Drugs Revenue Share by Manufacturers (2015-2020)
Table 17. Key Manufacturers Type 1 Diabetes Drugs Price (2015-2020) (USD/Unit)
Table 18. Type 1 Diabetes Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers Type 1 Diabetes Drugs Product Type
Table 20. Date of International Manufacturers Enter into Type 1 Diabetes Drugs Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Global Type 1 Diabetes Drugs Sales by Type (2015-2020) (K Units)
Table 23. Global Type 1 Diabetes Drugs Sales Share by Type (2015-2020)
Table 24. Global Type 1 Diabetes Drugs Revenue by Type (2015-2020) (US$ Million)
Table 25. Global Type 1 Diabetes Drugs Revenue Share by Type (2015-2020)
Table 26. Type 1 Diabetes Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 27. Global Type 1 Diabetes Drugs Sales by Application (2015-2020) (K Units)
Table 28. Global Type 1 Diabetes Drugs Sales Share by Application (2015-2020)
Table 29. North America Type 1 Diabetes Drugs Sales by Country (2015-2020) (K Units)
Table 30. North America Type 1 Diabetes Drugs Sales Market Share by Country (2015-2020)
Table 31. North America Type 1 Diabetes Drugs Revenue by Country (2015-2020) (US$ Million)
Table 32. North America Type 1 Diabetes Drugs Revenue Market Share by Country (2015-2020)
Table 33. North America Type 1 Diabetes Drugs Sales by Type (2015-2020) (K Units)
Table 34. North America Type 1 Diabetes Drugs Sales Market Share by Type (2015-2020)
Table 35. North America Type 1 Diabetes Drugs Sales by Application (2015-2020) (K Units)
Table 36. North America Type 1 Diabetes Drugs Sales Market Share by Application (2015-2020)
Table 37. Europe Type 1 Diabetes Drugs Sales by Country (2015-2020) (K Units)
Table 38. Europe Type 1 Diabetes Drugs Sales Market Share by Country (2015-2020)
Table 39. Europe Type 1 Diabetes Drugs Revenue by Country (2015-2020) (US$ Million)
Table 40. Europe Type 1 Diabetes Drugs Revenue Market Share by Country (2015-2020)
Table 41. Europe Type 1 Diabetes Drugs Sales by Type (2015-2020) (K Units)
Table 42. Europe Type 1 Diabetes Drugs Sales Market Share by Type (2015-2020)
Table 43. Europe Type 1 Diabetes Drugs Sales by Application (2015-2020) (K Units)
Table 44. Europe Type 1 Diabetes Drugs Sales Market Share by Application (2015-2020)
Table 45. Asia Pacific Type 1 Diabetes Drugs Sales by Region (2015-2020) (K Units)
Table 46. Asia Pacific Type 1 Diabetes Drugs Sales Market Share by Region (2015-2020)
Table 47. Asia Pacific Type 1 Diabetes Drugs Revenue by Region (2015-2020) (US$ Million)
Table 48. Asia Pacific Type 1 Diabetes Drugs Revenue Market Share by Region (2015-2020)
Table 49. Asia Pacific Type 1 Diabetes Drugs Sales by Type (2015-2020) (K Units)
Table 50. Asia Pacific Type 1 Diabetes Drugs Sales Market Share by Type (2015-2020)
Table 51. Asia Pacific Type 1 Diabetes Drugs Sales by Application (2015-2020) (K Units)
Table 52. Asia Pacific Type 1 Diabetes Drugs Sales Market Share by Application (2015-2020)
Table 53. Latin America Type 1 Diabetes Drugs Sales by Country (2015-2020) (K Units)
Table 54. Latin America Type 1 Diabetes Drugs Sales Market Share by Country (2015-2020)
Table 55. Latin Americaa Type 1 Diabetes Drugs Revenue by Country (2015-2020) (US$ Million)
Table 56. Latin America Type 1 Diabetes Drugs Revenue Market Share by Country (2015-2020)
Table 57. Latin America Type 1 Diabetes Drugs Sales by Type (2015-2020) (K Units)
Table 58. Latin America Type 1 Diabetes Drugs Sales Market Share by Type (2015-2020)
Table 59. Latin America Type 1 Diabetes Drugs Sales by Application (2015-2020) (K Units)
Table 60. Latin America Type 1 Diabetes Drugs Sales Market Share by Application (2015-2020)
Table 61. Middle East and Africa Type 1 Diabetes Drugs Sales by Country (2015-2020) (K Units)
Table 62. Middle East and Africa Type 1 Diabetes Drugs Sales Market Share by Country (2015-2020)
Table 63. Middle East and Africa Type 1 Diabetes Drugs Revenue by Country (2015-2020) (US$ Million)
Table 64. Middle East and Africa Type 1 Diabetes Drugs Revenue Market Share by Country (2015-2020)
Table 65. Middle East and Africa Type 1 Diabetes Drugs Sales by Type (2015-2020) (K Units)
Table 66. Middle East and Africa Type 1 Diabetes Drugs Sales Market Share by Type (2015-2020)
Table 67. Middle East and Africa Type 1 Diabetes Drugs Sales by Application (2015-2020) (K Units)
Table 68. Middle East and Africa Type 1 Diabetes Drugs Sales Market Share by Application (2015-2020)
Table 69. Novo Nordisk Corporation Information
Table 70. Novo Nordisk Description and Major Businesses
Table 71. Novo Nordisk Type 1 Diabetes Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 72. Novo Nordisk Product
Table 73. Novo Nordisk Recent Development
Table 74. Sanofi Corporation Information
Table 75. Sanofi Description and Major Businesses
Table 76. Sanofi Type 1 Diabetes Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 77. Sanofi Product
Table 78. Sanofi Recent Development
Table 79. Eli Lily Corporation Information
Table 80. Eli Lily Description and Major Businesses
Table 81. Eli Lily Type 1 Diabetes Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 82. Eli Lily Product
Table 83. Eli Lily Recent Development
Table 84. Adocia Corporation Information
Table 85. Adocia Description and Major Businesses
Table 86. Adocia Type 1 Diabetes Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 87. Adocia Product
Table 88. Adocia Recent Development
Table 89. Astellas Pharma Corporation Information
Table 90. Astellas Pharma Description and Major Businesses
Table 91. Astellas Pharma Type 1 Diabetes Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 92. Astellas Pharma Product
Table 93. Astellas Pharma Recent Development
Table 94. AstraZeneca Corporation Information
Table 95. AstraZeneca Description and Major Businesses
Table 96. AstraZeneca Type 1 Diabetes Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 97. AstraZeneca Product
Table 98. AstraZeneca Recent Development
Table 99. BHV Pharma Corporation Information
Table 100. BHV Pharma Description and Major Businesses
Table 101. BHV Pharma Type 1 Diabetes Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 102. BHV Pharma Product
Table 103. BHV Pharma Recent Development
Table 104. Biodel Corporation Information
Table 105. Biodel Description and Major Businesses
Table 106. Biodel Type 1 Diabetes Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 107. Biodel Product
Table 108. Biodel Recent Development
Table 109. Boehringer Ingelheim Corporation Information
Table 110. Boehringer Ingelheim Description and Major Businesses
Table 111. Boehringer Ingelheim Type 1 Diabetes Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 112. Boehringer Ingelheim Product
Table 113. Boehringer Ingelheim Recent Development
Table 114. Diamyd Therapeutics AB Corporation Information
Table 115. Diamyd Therapeutics AB Description and Major Businesses
Table 116. Diamyd Therapeutics AB Type 1 Diabetes Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. Diamyd Therapeutics AB Product
Table 118. Diamyd Therapeutics AB Recent Development
Table 119. Global Type 1 Diabetes Drugs Sales Forecast by Regions (2021-2026) (K Units)
Table 120. Global Type 1 Diabetes Drugs Sales Market Share Forecast by Regions (2021-2026)
Table 121. Global Type 1 Diabetes Drugs Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 122. Global Type 1 Diabetes Drugs Revenue Market Share Forecast by Regions (2021-2026)
Table 123. North America: Type 1 Diabetes Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 124. North America: Type 1 Diabetes Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 125. Europe: Type 1 Diabetes Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 126. Europe: Type 1 Diabetes Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 127. Asia Pacific: Type 1 Diabetes Drugs Sales Forecast by Region (2021-2026) (K Units)
Table 128. Asia Pacific: Type 1 Diabetes Drugs Revenue Forecast by Region (2021-2026) (US$ Million)
Table 129. Latin America: Type 1 Diabetes Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 130. Latin America: Type 1 Diabetes Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 131. Middle East and Africa: Type 1 Diabetes Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 132. Middle East and Africa: Type 1 Diabetes Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 133. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 134. Key Challenges
Table 135. Market Risks
Table 136. Main Points Interviewed from Key Type 1 Diabetes Drugs Players
Table 137. Type 1 Diabetes Drugs Customers List
Table 138. Type 1 Diabetes Drugs Distributors List
Table 139. Research Programs/Design for This Report
Table 140. Key Data Information from Secondary Sources
Table 141. Key Data Information from Primary Sources
List of Figures
Figure 1. Type 1 Diabetes Drugs Product Picture
Figure 2. Global Type 1 Diabetes Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Insulins Product Picture
Figure 4. Others Product Picture
Figure 5. Global Type 1 Diabetes Drugs Sales Market Share by Application in 2020 & 2026
Figure 6. Drugstore
Figure 7. Hospital
Figure 8. Others
Figure 9. Type 1 Diabetes Drugs Report Years Considered
Figure 10. Global Type 1 Diabetes Drugs Market Size 2015-2026 (US$ Million)
Figure 11. Global Type 1 Diabetes Drugs Sales 2015-2026 (K Units)
Figure 12. Global Type 1 Diabetes Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Global Type 1 Diabetes Drugs Sales Market Share by Region (2015-2020)
Figure 14. Global Type 1 Diabetes Drugs Sales Market Share by Region in 2019
Figure 15. Global Type 1 Diabetes Drugs Revenue Market Share by Region (2015-2020)
Figure 16. Global Type 1 Diabetes Drugs Revenue Market Share by Region in 2019
Figure 17. Global Type 1 Diabetes Drugs Sales Share by Manufacturer in 2019
Figure 18. The Top 10 and 5 Players Market Share by Type 1 Diabetes Drugs Revenue in 2019
Figure 19. Type 1 Diabetes Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global Type 1 Diabetes Drugs Sales Market Share by Type (2015-2020)
Figure 21. Global Type 1 Diabetes Drugs Sales Market Share by Type in 2019
Figure 22. Global Type 1 Diabetes Drugs Revenue Market Share by Type (2015-2020)
Figure 23. Global Type 1 Diabetes Drugs Revenue Market Share by Type in 2019
Figure 24. Global Type 1 Diabetes Drugs Market Share by Price Range (2015-2020)
Figure 25. Global Type 1 Diabetes Drugs Sales Market Share by Application (2015-2020)
Figure 26. Global Type 1 Diabetes Drugs Sales Market Share by Application in 2019
Figure 27. Global Type 1 Diabetes Drugs Revenue Market Share by Application (2015-2020)
Figure 28. Global Type 1 Diabetes Drugs Revenue Market Share by Application in 2019
Figure 29. North America Type 1 Diabetes Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 30. North America Type 1 Diabetes Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 31. North America Type 1 Diabetes Drugs Sales Market Share by Country in 2019
Figure 32. North America Type 1 Diabetes Drugs Revenue Market Share by Country in 2019
Figure 33. U.S. Type 1 Diabetes Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 34. U.S. Type 1 Diabetes Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Canada Type 1 Diabetes Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 36. Canada Type 1 Diabetes Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. North America Type 1 Diabetes Drugs Market Share by Type in 2019
Figure 38. North America Type 1 Diabetes Drugs Market Share by Application in 2019
Figure 39. Europe Type 1 Diabetes Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 40. Europe Type 1 Diabetes Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 41. Europe Type 1 Diabetes Drugs Sales Market Share by Country in 2019
Figure 42. Europe Type 1 Diabetes Drugs Revenue Market Share by Country in 2019
Figure 43. Germany Type 1 Diabetes Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 44. Germany Type 1 Diabetes Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. France Type 1 Diabetes Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 46. France Type 1 Diabetes Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. U.K. Type 1 Diabetes Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 48. U.K. Type 1 Diabetes Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Italy Type 1 Diabetes Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 50. Italy Type 1 Diabetes Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Russia Type 1 Diabetes Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 52. Russia Type 1 Diabetes Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Europe Type 1 Diabetes Drugs Market Share by Type in 2019
Figure 54. Europe Type 1 Diabetes Drugs Market Share by Application in 2019
Figure 55. Asia Pacific Type 1 Diabetes Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 56. Asia Pacific Type 1 Diabetes Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 57. Asia Pacific Type 1 Diabetes Drugs Sales Market Share by Region in 2019
Figure 58. Asia Pacific Type 1 Diabetes Drugs Revenue Market Share by Region in 2019
Figure 59. China Type 1 Diabetes Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 60. China Type 1 Diabetes Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Japan Type 1 Diabetes Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 62. Japan Type 1 Diabetes Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. South Korea Type 1 Diabetes Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 64. South Korea Type 1 Diabetes Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. India Type 1 Diabetes Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 66. India Type 1 Diabetes Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Australia Type 1 Diabetes Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 68. Australia Type 1 Diabetes Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Taiwan Type 1 Diabetes Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 70. Taiwan Type 1 Diabetes Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Indonesia Type 1 Diabetes Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 72. Indonesia Type 1 Diabetes Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Thailand Type 1 Diabetes Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 74. Thailand Type 1 Diabetes Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Malaysia Type 1 Diabetes Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 76. Malaysia Type 1 Diabetes Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Philippines Type 1 Diabetes Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 78. Philippines Type 1 Diabetes Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Vietnam Type 1 Diabetes Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 80. Vietnam Type 1 Diabetes Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Asia Pacific Type 1 Diabetes Drugs Market Share by Type in 2019
Figure 82. Asia Pacific Type 1 Diabetes Drugs Market Share by Application in 2019
Figure 83. Latin America Type 1 Diabetes Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 84. Latin America Type 1 Diabetes Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 85. Latin America Type 1 Diabetes Drugs Sales Market Share by Country in 2019
Figure 86. Latin America Type 1 Diabetes Drugs Revenue Market Share by Country in 2019
Figure 87. Mexico Type 1 Diabetes Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 88. Mexico Type 1 Diabetes Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 89. Brazil Type 1 Diabetes Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 90. Brazil Type 1 Diabetes Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Argentina Type 1 Diabetes Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 92. Argentina Type 1 Diabetes Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Latin America Type 1 Diabetes Drugs Market Share by Type in 2019
Figure 94. Latin America Type 1 Diabetes Drugs Market Share by Application in 2019
Figure 95. Middle East and Africa Type 1 Diabetes Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 96. Middle East and Africa Type 1 Diabetes Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 97. Middle East and Africa Type 1 Diabetes Drugs Sales Market Share by Country in 2019
Figure 98. Middle East and Africa Type 1 Diabetes Drugs Revenue Market Share by Country in 2019
Figure 99. Turkey Type 1 Diabetes Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 100. Turkey Type 1 Diabetes Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 101. Saudi Arabia Type 1 Diabetes Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 102. Saudi Arabia Type 1 Diabetes Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. U.A.E Type 1 Diabetes Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 104. U.A.E Type 1 Diabetes Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Middle East and Africa Type 1 Diabetes Drugs Market Share by Type in 2019
Figure 106. Middle East and Africa Type 1 Diabetes Drugs Market Share by Application in 2019
Figure 107. North America Type 1 Diabetes Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 108. North America Type 1 Diabetes Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 109. Europe Type 1 Diabetes Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 110. Europe Type 1 Diabetes Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 111. Asia Pacific Type 1 Diabetes Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 112. Asia Pacific Type 1 Diabetes Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Latin America Type 1 Diabetes Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 114. Latin America Type 1 Diabetes Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Middle East and Africa Type 1 Diabetes Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 116. Middle East and Africa Type 1 Diabetes Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Porter's Five Forces Analysis
Figure 118. Channels of Distribution
Figure 119. Distributors Profiles
Figure 120. Bottom-up and Top-down Approaches for This Report
Figure 121. Data Triangulation
Figure 122. Key Executives Interviewed


【掲載企業】

Novo Nordisk、Sanofi、Eli Lily、Adocia、Astellas Pharma、AstraZeneca、BHV Pharma、Biodel、Boehringer Ingelheim、Diamyd Therapeutics AB

★調査レポート[世界の1型糖尿病治療薬市場インサイト及び予測(~2026年)] (コード:QYR20NV12796)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の1型糖尿病治療薬市場インサイト及び予測(~2026年)]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆